Simplex Trading’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,581
Closed -$15.7M 8502
2019
Q3
$15.7M Buy
1,581
+52
+3% +$4.94K 0.04% 289
2019
Q2
$14.1M Sell
1,529
-3,852
-72% -$366K 0.04% 306
2019
Q1
$50.8M Buy
5,381
+322
+6% +$28.2K 0.14% 92
2018
Q4
$32.4M Buy
5,059
+745
+17% +$55K 0.1% 130
2018
Q3
$38.6M Sell
4,314
-121
-3% -$10.7K 0.12% 110
2018
Q2
$35.2M Sell
4,435
-2,011
-31% -$167K 0.14% 105
2018
Q1
$984K Buy
6,446
+2,248
+54% +$216K 0.04% 399
2017
Q4
$1.07M Buy
4,198
+424
+11% +$47.8K 0.05% 370
2017
Q3
$4.97M Sell
3,774
-535
-12% -$72.9K 0.2% 77
2017
Q2
$4.97M Buy
4,309
+1,228
+40% +$150K 0.22% 73
2017
Q1
$1.85M Sell
3,081
-599
-16% -$71.7K 0.08% 220
2016
Q4
$1.51M Sell
3,680
-149
-4% -$16.6K 0.09% 178
2016
Q3
$624K Buy
3,829
+1,080
+39% +$117K 0.04% 426
2016
Q2
$480K Sell
2,749
-1,133
-29% -$117K 0.03% 537
2016
Q1
$527K Buy
3,882
+1,117
+40% +$115K 0.04% 422
2015
Q4
$4.03M Sell
2,765
-1,242
-31% -$144K 0.32% 49
2015
Q3
$2.39M Buy
4,007
+1,041
+35% +$129K 0.18% 103
2015
Q2
$2.65M Sell
2,966
-928
-24% -$106K 0.22% 75
2015
Q1
$3.69M Buy
3,894
+425
+12% +$50.8K 0.43% 34
2014
Q4
$6.12M Buy
+3,469
New +$366K 0.74% 17

Other funds holding CELG

Simplex Trading's CELG Position: Q4 2019 in Review

Simplex Trading sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 24,695 shares — an estimated $2.45M sold.

Simplex Trading first reported a position in CELG in Q4 2014 and held it in 18 quarters. The position peaked at $29.2M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Simplex Trading reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Simplex Trading sold 24,695 Celgene Corp shares in Q4 2019, an estimated $2.45M.
  • Simplex Trading first reported a position in Celgene Corp in Q4 2014 and held it in 18 quarters.
  • Simplex Trading's Celgene Corp position peaked at $29.2M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.